Endologix (ELGX) : Endologix (ELGX) had a healthy money flow of $0.14 million into the stock during the Thursdays trading session. The value of bullish trades on upticks was $0.19 million, whereas, investors only sold shares worth $0.05 million on downticks. The stock closed the day with an up-down ratio of 3.57.The money flow in the block trades to the tune of $0.17 million shows that the bulls were dominant, the large players used the weakness in the stock to accumulate it for the long-term. $0.17 million worth of transactions were on upticks. Endologix (ELGX) stock slid $0.03 intraday and traded at 13.89, a change of -0.22% over previous days close. However, for the week, the company shares are -2.46% compared to previous weeks close.
The stock has recorded a 20-day Moving Average of 8.91% and the 50-Day Moving Average is 12.64%. Shares have dropped -8.81% from its 1 Year high price. On Jul 15, 2015, the shares registered one year high at $15.53 and the one year low was seen on Feb 9, 2016. The 50-Day Moving Average price is $12.70 and the 200 Day Moving Average price is recorded at $10.07.
Endologix (NASDAQ:ELGX): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $14.14 and $13.78 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $14.14. The buying momentum continued till the end and the stock did not give up its gains. It closed at $13.99, notching a gain of 0.50% for the day. The total traded volume was 627,792 . The stock had closed at $13.92 on the previous day.
In an insider trading activity, The Securities and Exchange Commission has divulged that Waller Gregory D, director of Endologix Inc /De/, had unloaded 7,800 shares at an average price of $12.86 in a transaction dated on June 3, 2016. The total value of the transaction was worth $100,308.
Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Companys products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms: traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The Companys EVAS product is based on the Nellix platform to seal the aneurysm and provide blood flow to the legs through two blood lumens.